| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,893 | 54,742 | 54,851 | 73,608 | | Cost of Revenue | 20,050 | 50,354 | 52,335 | 79,595 | | | Gross Profit | (157) | 4,388 | 2,516 | (5,987) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,050 | 8,657 | 5,823 | 7,643 | | Non Recurring | 585 | 402 | 760 | 979 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,792) | (4,671) | (4,067) | (14,609) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (916) | 939 | 203 | 195 | | Earnings Before Interest And Taxes | (6,548) | (3,732) | (3,864) | (14,414) | | Interest Expense |
-
| (414) | 414 | 581 | | Income Before Tax | (6,548) | (3,318) | (4,278) | (14,995) | | Income Tax Expense | (2,501) | (2,220) | (1,948) | (5,527) | | Minority Interest | 236 | (668) | (158) | 190 | | | | Net Income From Continuing Ops | (3,811) | (1,766) | (2,488) | (9,278) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,811) | (1,766) | (2,488) | (9,278) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,811) | ($1,766) | ($2,488) | ($9,278) |
|
0.22% Nasdaq 
Income Statement
